The importance of collaboration across fields and institutions
Diagnosis and Initial Treatment of CLL
Peter Hillmen et al.
Features of high-risk multiple myeloma and how to treat it
Era of personalized therapy in CLL
Can ibrutinib be used as a first-line treatment in CLL?